Pregnancy, asthma and exacerbations: a population-based cohort
Despite fewer total exacerbations, exacerbations associated with a hospital admission increased during pregnancy. One third of women reduced inhaled corticosteroid use during pregnancy, yet this was the second largest exacerbation risk factor and is completely modifiable. Other major risk factors were type 2 inflammation and another modifiable risk factor, suboptimal asthma control pre-pregnancy.
Authors
- Tricia Tan (ORCID: https://orcid.org/0000-0001-5873-3432)
- Bohee Lee (ORCID: https://orcid.org/0000-0002-9671-386X)
- Chloë I. Bloom (ORCID: https://orcid.org/0000-0003-1285-7602)
- Hitasha Rupani (ORCID: https://orcid.org/0000-0002-0150-138X)
- Ernie Wong (ORCID: https://orcid.org/0000-0002-3081-9696)
Institutions
- University Hospital Southampton NHS Foundation Trust (GB)
- Lung Institute (US)
- Imperial College London (GB)
Publication Details
- Journal
- European Respiratory Journal
- Published
- 2025-08-28
- DOI
- https://doi.org/10.1183/13993003.01327-2025
- Citations
- 4
- Primary Topic
- Pregnancy and Medication Impact
- Type
- article
- Field-Weighted Citation Impact
- 7.51
Funders
- Asthma and Lung UK